{"date":"2025-08-08","count":105,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4157-2025-08-08-2356-52gmte","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"23:56:56","subject":"公告本公司自114年8月12日起恢復為普通交割方式之買賣","clause":"第1款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-08-08 23:56，「公告本公司自114年8月12日起恢復為普通交割方式之買賣」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6939-2025-08-08-2340-14s01ic","company_id":"6939","company":"啟弘生技","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"23:40:05","subject":"公告本公司董事會通過114年第2季財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：啟弘生技（6939），2025-08-08 23:40，「公告本公司董事會通過114年第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-08-08-2203-3i9wn4","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"22:03:23","subject":"公告本公司決議除權息暨增資基準日等相關事宜","clause":"第14款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-08-08 22:03，「公告本公司決議除權息暨增資基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2025-08-08-2121-1ub20ox","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"21:21:59","subject":"更正本公司114年第二季合併財務報告iXBRL申報資訊","clause":"第53款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2025-08-08 21:21，「更正本公司114年第二季合併財務報告iXBRL申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-2044-svroaj","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"20:44:11","subject":"代重要子公司越南普惠醫療工藝責任有限公司公告與關係人提前終止使用權資產契約","clause":"第17款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 20:44，「代重要子公司越南普惠醫療工藝責任有限公司公告與關係人提前終止使用權資產契約」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-08-08-1919-1u9jfij","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"19:19:28","subject":"公告本公司董事會通過總經理任用案","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-08-08 19:19，「公告本公司董事會通過總經理任用案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-08-1854-e3r4ix","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:54:44","subject":"召集本公司114年第一次股東臨時會案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-08 18:54，「召集本公司114年第一次股東臨時會案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-08-08-1825-13r622w","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"18:25:53","subject":"公告本公司第二廠完成國產醫療器材品質管理系統(QMS)查廠作業，查核結果無重大缺失","clause":"第44款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-08-08 18:25，「公告本公司第二廠完成國產醫療器材品質管理系統(QMS)查廠作業，查核結果無重大缺失」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-08-08-1825-1fqkmsr","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"18:25:00","subject":"澄清媒體報導","clause":"第26款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-08-08 18:25，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-08-08-1822-zww1ev","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"18:22:58","subject":"公告與越南VGCT簽訂總經銷合約(補充說明)","clause":"第8款","fact_date":"2025-07-25","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-08-08 18:22，「公告與越南VGCT簽訂總經銷合約(補充說明)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-08-1818-1ecufqy","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:18:05","subject":"本公司改派鄭至閔先生為代理發言人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-08 18:18，「本公司改派鄭至閔先生為代理發言人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-08-1817-cavxig","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:17:24","subject":"本公司改派蔡侑潭先生為發言人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-08 18:17，「本公司改派蔡侑潭先生為發言人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2025-08-08-1817-140kqs7","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:17:08","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2025-08-08 18:17，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1808-ex99il","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:08:20","subject":"公告本公司董事會決議通過重要子公司Handa Pharma Inc.對其子公司之資金貸與債權全數轉增資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:08，「公告本公司董事會決議通過重要子公司Handa Pharma Inc.對其子公司之資金貸與債權全數轉增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1807-v3zacu","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:07:59","subject":"代子公司Handa Pharma, Inc公告董事變動達三分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:07，「代子公司Handa Pharma, Inc公告董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1807-17hxk3d","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:07:39","subject":"本公司董事會通過解除經理人競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:07，「本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1807-xo2pc7","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:07:18","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:07，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1806-x1ohmw","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:06:57","subject":"公告本公司限制員工權利新股增資基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:06，「公告本公司限制員工權利新股增資基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1806-13xoyh9","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:06:36","subject":"公告本公司董事會追認修訂114年度限制員工權利新股發行辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:06，「公告本公司董事會追認修訂114年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1805-xyhazt","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:05:40","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:05，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-08-08-1805-i0ww4a","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"18:05:14","subject":"更正本公司114年4月營收及114年4-6月各月累計營收","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-08-08 18:05，「更正本公司114年4月營收及114年4-6月各月累計營收」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2025-08-08-1757-r9xals","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:57:05","subject":"代重要子公司佳醫資產管理事業股份有限公司公告董事會選任董事長","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2025-08-08 17:57，「代重要子公司佳醫資產管理事業股份有限公司公告董事會選任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1752-c84rw","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"17:52:57","subject":"本公司董事會決議通過一一四年上半年度不發放股利","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 17:52，「本公司董事會決議通過一一四年上半年度不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-08-1747-1e4x8h6","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:47:20","subject":"公告本公司董事會通過114年第2季財務報表","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-08 17:47，「公告本公司董事會通過114年第2季財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-08-1747-oi9rmi","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:47:04","subject":"本公司董事會決議收回已發行之限制員工權利新股註銷減資事宜","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-08 17:47，「本公司董事會決議收回已發行之限制員工權利新股註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-08-1746-1nnt8f1","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:46:46","subject":"公告本公司董事會通過解除經理人競業禁止之限制","clause":"第21款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-08 17:46，「公告本公司董事會通過解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-08-1746-1q7cguv","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:46:30","subject":"公告本公司研發主管任命案","clause":"第8款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-08 17:46，「公告本公司研發主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-08-08-1746-i8tame","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:46:07","subject":"公告本公司董事會通過總經理任命案","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-08-08 17:46，「公告本公司董事會通過總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-08-08-1744-1u4weur","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"17:44:51","subject":"公告本公司董事會委任薪資報酬委員會第三屆委員","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-08-08 17:44，「公告本公司董事會委任薪資報酬委員會第三屆委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6758-2025-08-08-1743-1xtjtmq","company_id":"6758","company":"冠亞","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"17:43:23","subject":"公告本公司董事會通過114年第二季財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：冠亞（6758），2025-08-08 17:43，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-08-08-1738-fxkrde","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:38:38","subject":"公告本公司薪資報酬委員會委員辭任","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-08-08 17:38，「公告本公司薪資報酬委員會委員辭任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-08-1733-e7i9dp","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:33:53","subject":"公告本公司董事會通過114年度第2季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-08 17:33，「公告本公司董事會通過114年度第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-08-1732-1xjkc6g","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:32:53","subject":"公告本公司董事會決議更名全面換發有價證券相關事宜","clause":"第51款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-08 17:32，「公告本公司董事會決議更名全面換發有價證券相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-08-1731-139tylo","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:31:11","subject":"(更正-(1)盈餘分配之現金股利(元/股)) 公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2025-03-11","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-08 17:31，「(更正-(1)盈餘分配之現金股利(元/股)) 公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-08-08-1729-1wxv6d7","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:29:26","subject":"本公司董事會決議通過本公司114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-08-08 17:29，「本公司董事會決議通過本公司114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-08-1727-1k4l4c4","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:27:46","subject":"公告本公司董事會決議修訂113年度限制員工權利新股發行辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-08 17:27，「公告本公司董事會決議修訂113年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-08-08-1727-ebt79d","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:27:42","subject":"向關係人處分使用權資產提前終止租約案","clause":"第20款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-08-08 17:27，「向關係人處分使用權資產提前終止租約案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2025-08-08-1726-i37hx2","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:26:10","subject":"公告本公司114年第2季合併財務報告業經提報董事會通過","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2025-08-08 17:26，「公告本公司114年第2季合併財務報告業經提報董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-08-08-1724-1eowrfm","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:24:52","subject":"代重要子公司優品生醫股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告","clause":"第23款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-08-08 17:24，「代重要子公司優品生醫股份有限公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-08-1718-1v2ow1y","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:18:24","subject":"本公司114年第二季合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-08 17:18，「本公司114年第二季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2025-08-08-1717-1pulss0","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:17:42","subject":"本公司聘任蔡侑潭先生為執行長","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2025-08-08 17:17，「本公司聘任蔡侑潭先生為執行長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-08-1715-9ws87k","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:15:34","subject":"公告本公司董事會通過第三次買回庫藏股","clause":"第35款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-08 17:15，「公告本公司董事會通過第三次買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-08-08-1714-vqjh9g","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:14:31","subject":"公告本公司董事會決議發行國內第一次無擔保轉換公司債","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-08-08 17:14，「公告本公司董事會決議發行國內第一次無擔保轉換公司債」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-08-1714-1reebha","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:14:24","subject":"公告本公司追認修訂114年度限制員工權利新股發行辦法","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-08 17:14，「公告本公司追認修訂114年度限制員工權利新股發行辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-08-08-1714-1ifcdw5","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:14:03","subject":"本公司董事會決議114年發行限制員工權利新股之增資基準日","clause":"第51款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-08-08 17:14，「本公司董事會決議114年發行限制員工權利新股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-08-08-1710-hcclaf","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:10:51","subject":"代重要子公司優品生醫股份有限公司公告決議盈餘分配案","clause":"第14款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-08-08 17:10，「代重要子公司優品生醫股份有限公司公告決議盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-08-08-1709-xyhazt","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:09:02","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-08-08 17:09，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1707-1eebz3t","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:07:43","subject":"公告本公司薪資報酬委員會委員異動","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 17:07，「公告本公司薪資報酬委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1706-13sk2v0","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:06:15","subject":"公告本公司審計委員會委員異動","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 17:06，「公告本公司審計委員會委員異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-08-08-1705-h5btcv","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:05:58","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告","clause":"第23款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-08-08 17:05，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第三款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1784-2025-08-08-1705-11o7h8s","company_id":"1784","company":"訊聯","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:05:39","subject":"衛福部核准本公司與奇美醫療財團法人奇美醫院合作之自體脂肪幹細胞治療慢性或滿六週未癒合之困難傷口計畫","clause":"第53款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：訊聯（1784），2025-08-08 17:05，「衛福部核准本公司與奇美醫療財團法人奇美醫院合作之自體脂肪幹細胞治療慢性或滿六週未癒合之困難傷口計畫」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-08-08-1705-9gui2j","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:05:36","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告","clause":"第23款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-08-08 17:05，「本公司依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7827-2025-08-08-1705-1xtnczi","company_id":"7827","company":"漢康-KY創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"17:05:14","subject":"公告本公司114年第一次現金增資認股基準日暨相關事宜。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢康-KY創（7827），2025-08-08 17:05，「公告本公司114年第一次現金增資認股基準日暨相關事宜。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1704-p9bs5i","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:04:30","subject":"公告本公司重要營運主管異動","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 17:04，「公告本公司重要營運主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1703-1o6otne","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:03:17","subject":"公告本公司董事會通過民國114年第二季財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 17:03，「公告本公司董事會通過民國114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1702-tudii0","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"17:02:11","subject":"公告本公司114年第二次股東臨時會通過解除本公司董事及其代表人競業禁止之限制案。","clause":"第22款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 17:02，「公告本公司114年第二次股東臨時會通過解除本公司董事及其代表人競業禁止之限制案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1659-1jc4mfz","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:59:21","subject":"公告本公司114年第二次股東臨時會增選獨立董事當選名單","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 16:59，「公告本公司114年第二次股東臨時會增選獨立董事當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1658-5lujnd","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"16:58:49","subject":"本公司董事會決議資金貸與子公司越南普惠醫療工藝責任有限公司","clause":"第20款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 16:58，「本公司董事會決議資金貸與子公司越南普惠醫療工藝責任有限公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-08-08-1658-aa2zln","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:58:22","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-08-08 16:58，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-08-08-1655-140kqs7","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:55:51","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-08-08 16:55，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2025-08-08-1655-12lfawl","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:55:36","subject":"本公司董事會決議召開114年第二次股東臨時會相關事宜(新增議案)","clause":"第32款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2025-08-08 16:55，「本公司董事會決議召開114年第二次股東臨時會相關事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2025-08-08-1654-xyhazt","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"16:54:16","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2025-08-08 16:54，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6986-2025-08-08-1653-1ye5yun","company_id":"6986","company":"和迅","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:53:51","subject":"公告本公司114年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：和迅（6986），2025-08-08 16:53，「公告本公司114年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4128-2025-08-08-1651-1p3d51","company_id":"4128","company":"中天","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:51:22","subject":"公告本公司董事會決議通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：中天（4128），2025-08-08 16:51，「公告本公司董事會決議通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-08-1647-1ev1paf","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:47:21","subject":"本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-08 16:47，「本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-08-1638-tudzk1","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:38:26","subject":"公告本公司董事會決議辦理限制員工權利新股收買註銷減資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-08 16:38，「公告本公司董事會決議辦理限制員工權利新股收買註銷減資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-08-08-1630-87995d","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:30:57","subject":"公告本公司董事會決議解除經理人競業限制","clause":"第21款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-08-08 16:30，「公告本公司董事會決議解除經理人競業限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2025-08-08-1630-1m5wzpd","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:30:10","subject":"本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2025-08-08 16:30，「本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-08-08-1626-xoscjz","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:26:15","subject":"公告本公司財務主管、公司治理主管及代理發言人異動","clause":"第8款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-08-08 16:26，「公告本公司財務主管、公司治理主管及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-08-08-1625-1qdc5wq","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:25:02","subject":"本公司董事會決議辦理一般板初次上市掛牌前現金增資發行新股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-08-08 16:25，「本公司董事會決議辦理一般板初次上市掛牌前現金增資發行新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-08-08-1618-xyhazt","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"16:18:23","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-08-08 16:18，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-08-08-1618-13gpkf1","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"16:18:12","subject":"公告本公司受邀參加鑽石生技投資與臺灣證券交易所、櫃檯買賣中心共同主辦「2025亞太生技投資論壇」","clause":"第30款","fact_date":"2025-08-11","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-08-08 16:18，「公告本公司受邀參加鑽石生技投資與臺灣證券交易所、櫃檯買賣中心共同主辦「2025亞太生技投資論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-08-08-1618-1xtjtmq","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:18:11","subject":"公告本公司董事會通過114年第二季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-08-08 16:18，「公告本公司董事會通過114年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2025-08-08-1617-1cccuo4","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"16:17:34","subject":"公告本公司董事長訂定除息基準日","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2025-08-08 16:17，「公告本公司董事長訂定除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-08-08-1614-xyhazt","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"16:14:23","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-08-08 16:14，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4108-2025-08-08-1613-xyhazt","company_id":"4108","company":"懷特","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:13:51","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：懷特（4108），2025-08-08 16:13，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-08-1609-1qc2d9e","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:09:19","subject":"公告本公司董事會決議114年第2季虧損撥補暨114年第2季不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-08 16:09，「公告本公司董事會決議114年第2季虧損撥補暨114年第2季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2025-08-08-1606-xyhazt","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"16:06:03","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2025-08-08 16:06，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6817-2025-08-08-1600-xyhazt","company_id":"6817","company":"溫士頓","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"16:00:46","subject":"公告本公司董事會通過114年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：溫士頓（6817），2025-08-08 16:00，「公告本公司董事會通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-08-08-1553-jh5t0","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:53:34","subject":"公告本公司董事會通過114年Q2個別財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-08-08 15:53，「公告本公司董事會通過114年Q2個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7784-2025-08-08-1544-opt40w","company_id":"7784","company":"安邦生技*","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:44:24","subject":"公告本公司董事會通過114年度上半年度合併財務報告","clause":"第9款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：安邦生技*（7784），2025-08-08 15:44，「公告本公司董事會通過114年度上半年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-08-08-1534-4rznsb","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"15:34:44","subject":"本公司民國114年第二季合併財務報告業經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-08-08 15:34，「本公司民國114年第二季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-08-08-1533-tjxx6d","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"15:33:51","subject":"本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-08-08 15:33，「本公司董事會決議將未符既得條件之限制員工權利新股收回註銷調整資本額」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-08-08-1530-ncrpbg","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:30:17","subject":"公告本公司向泰國食品藥物管理局(Thai FDA)提出安特羅腸病毒71型疫苗新藥審查(NDA)申請","clause":"第44款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-08-08 15:30，「公告本公司向泰國食品藥物管理局(Thai FDA)提出安特羅腸病毒71型疫苗新藥審查(NDA)申請」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-08-08-1523-1siesrk","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"15:23:15","subject":"公告本公司董事會決議成立第一屆永續發展委員會","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-08-08 15:23，「公告本公司董事會決議成立第一屆永續發展委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-08-08-1522-140kqs7","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"15:22:27","subject":"公告本公司董事會通過114年度第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-08-08 15:22，「公告本公司董事會通過114年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-08-08-1521-17up2wc","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"15:21:49","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-08-08 15:21，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1518-11ftjh8","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:18:23","subject":"公告本公司董事會任命資安主管","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 15:18，「公告本公司董事會任命資安主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1517-1q5urfr","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:17:54","subject":"公告本公司董事會決議通過委任第一屆永續發展委員會成員","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 15:17，「公告本公司董事會決議通過委任第一屆永續發展委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1517-ydfna0","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:17:30","subject":"公告本公司董事會決議通過委任第五屆薪資報酬委員會成員","clause":"第6款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 15:17，「公告本公司董事會決議通過委任第五屆薪資報酬委員會成員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1517-isqttc","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:17:05","subject":"公告本公司董事會重要決議事項","clause":"第44款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 15:17，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-08-08-1516-17lnd4r","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"15:16:59","subject":"公告本公司董事會決議更換會計師事務所及簽證會計師","clause":"第7款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-08-08 15:16，「公告本公司董事會決議更換會計師事務所及簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2025-08-08-1516-1djl5d2","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2025-08-08","time":"15:16:36","subject":"公告本公司董事會通過一一四年第二季合併財務報告","clause":"第43款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2025-08-08 15:16，「公告本公司董事會通過一一四年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-08-08-1513-1xdmtzf","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"15:13:29","subject":"本公司受邀參加統一證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-08-08 15:13，「本公司受邀參加統一證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1733-2025-08-08-1511-aa2zln","company_id":"1733","company":"五鼎","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"15:11:52","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：五鼎（1733），2025-08-08 15:11，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6841-2025-08-08-1509-muluxb","company_id":"6841","company":"長佳智能","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"15:09:04","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：長佳智能（6841），2025-08-08 15:09，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6645-2025-08-08-1454-aa2zln","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"14:54:04","subject":"公告本公司董事會通過114年第2季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-08-08 14:54，「公告本公司董事會通過114年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-08-08-1442-1d0jj0u","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"14:42:26","subject":"公告本公司董事會通過114年度第2季財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-08-08 14:42，「公告本公司董事會通過114年度第2季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-08-08-1441-1cdq0nw","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"14:41:53","subject":"公告本公司114年第二季合併財務報告提報董事會","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-08-08 14:41，「公告本公司114年第二季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-08-08-1434-tcoaem","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-08-08","time":"14:34:05","subject":"本公司內部稽核異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-08-08 14:34，「本公司內部稽核異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-08-08-1431-muluxb","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"14:31:47","subject":"公告本公司董事會決議通過114年第二季合併財務報告","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-08-08 14:31，「公告本公司董事會決議通過114年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-08-08-1413-aru34f","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"14:13:56","subject":"公告本公司董事會通過研發主管異動追認案","clause":"第8款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-08-08 14:13，「公告本公司董事會通過研發主管異動追認案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-08-08-1408-r0m69i","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"14:08:58","subject":"公告本公司董事會決議註銷庫藏股及訂定減資基準日","clause":"第11款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-08-08 14:08，「公告本公司董事會決議註銷庫藏股及訂定減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3164-2025-08-08-1401-1cdq0nw","company_id":"3164","company":"景岳","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"14:01:59","subject":"公告本公司114年第二季合併財務報告提報董事會","clause":"第31款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：景岳（3164），2025-08-08 14:01，「公告本公司114年第二季合併財務報告提報董事會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2025-08-08-1340-1nafrsr","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2025-08-08","time":"13:40:35","subject":"更正本公司113年1月~114年6月當期及累計營收公告，營收更正並無影響本公司損益金額。","clause":"第44款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2025-08-08 13:40，「更正本公司113年1月~114年6月當期及累計營收公告，營收更正並無影響本公司損益金額。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}